Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 4:52 pm Purchase | 2026-03-02 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Ray Prudo, M.D. | 209,783,162 8.900% | 86,618,142 (+70.33%) | Filing History |
| 2026-03-04 4:44 pm Purchase | 2026-03-02 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Samir R. Patel | 243,130,375 10.400% | 99,484,521 (+69.26%) | Filing History |
| 2026-03-04 4:44 pm Purchase | 2026-03-02 | 13G | AKARI THERAPEUTICS PLC SPONSOR AKTX | Hoyoung Huh, M.D., Ph.D. | 454,992,442 18.400% | 247,629,742 (+119.42%) | Filing History |
| 2025-02-14 5:00 pm Purchase | 2024-11-14 | 13G | AKARI THERAPEUTICS PLC SPONSOR AKTX | Hoyoung Huh, M.D., Ph.D. | 207,362,700 15.500% | 207,362,700 (New Position) | Filing History |
| 2025-02-14 5:00 pm Purchase | 2024-11-14 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Ray Prudo, M.D. | 123,165,020 9.300% | 123,165,020 (New Position) | Filing History |
| 2024-12-06 4:00 pm Purchase | 2024-11-14 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Samir R. Patel | 143,645,854 10.850% | 58,316,800 (+68.34%) | Filing History |
| 2024-06-20 07:30 am Purchase | 2024-05-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 112,682,870 19.200% | 25,558,922 (+29.34%) | Filing History |
| 2024-06-18 4:15 pm Purchase | 2024-05-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Theofilos Charles Steve | 59,268,750 9.990% | 59,268,750 (New Position) | Filing History |
| 2024-06-07 6:00 pm Purchase | 2024-05-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Samir R. Patel | 85,329,054 14.500% | 85,319,226 (+868123.99%) | Filing History |
| 2024-01-04 12:34 pm Purchase | 2024-01-01 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 87,123,948 26.400% | 23,696,700 (+37.36%) | Filing History |
| 2023-10-20 5:00 pm Purchase | 2023-10-06 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 63,427,248 21.800% | 60,558,617 (+2111.06%) | Filing History |
| 2023-04-14 4:06 pm Purchase | 2023-03-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 2,868,631 22.700% | 1,700,948 (+145.67%) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | AKARI THERAPEUTICS PLC SPONSOR AKTX | Samir R. Patel | 9,828 9.900% | 5,230 (+113.75%) | Filing History |
| 2022-02-14 08:02 am Purchase | 2021-12-31 | 13G | AKARI THERAPEUTICS PLC SPONSOR AKTX | Samir R. Patel | 4,598 6.200% | 1,483 (+47.61%) | Filing History |
| 2022-01-14 4:18 pm Purchase | 2021-12-29 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 1,167,683 18.000% | 50,575 (+4.53%) | Filing History |
| 2021-10-18 5:06 pm Purchase | 2021-07-07 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 1,117,108 18.800% | 76,512 (+7.35%) | Filing History |